Brainsway Ltd.
Business
BrainsWay Ltd. develops and commercializes advanced noninvasive neurostimulation therapies using its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform to treat psychiatric, neurological and addiction disorders. Its main products and services include Deep TMS systems comprising proprietary H‑Coil helmets, stimulators, cooling and positioning components, clinical treatment protocols (including theta‑burst and accelerated protocols), training, installation, service and leasing or purchase programs. The company operates clinical research and commercial R&D segments alongside direct sales and service operations. It primarily targets the U.S. market and also sells through distributors and direct channels across Europe, Asia, Canada, Israel and other international territories.
Summary from filing dated 2025-04-22
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $7.58M |
| Total assets | $113.19M |
| Total liabilities | — |
| Stockholders' equity | — |
| Operating cash flow | — |